| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CIMETIDINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
CIMETIDINE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
PRIMIDONE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
PRIMIDONE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
TROVAFLOXACIN |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
BETAMETHASONE PHOSPHATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BETAMETHASONE PHOSPHATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 2 |
BENZYL ALCOHOL |
Chemokine CCR2B |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
(R)-BICALUTAMIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
(R)-BICALUTAMIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
BETAHISTINE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
BETAHISTINE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
BETAHISTINE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
BETAHISTINE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
BETAHISTINE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
GOLD SODIUM THIOMALATE |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
SULFANILAMIDE |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
SULFANILAMIDE |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
BLEOMYCIN A2 |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
BLEOMYCIN A2 |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
AMINOGLUTETHIMIDE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
PACLITAXEL |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
PACLITAXEL |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
PACLITAXEL |
Potassium Channel [KATP] |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
TACROLIMUS |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
STANNOUS FLUORIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
STANNOUS FLUORIDE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
ACETAMINOPHEN |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
TACROLIMUS |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
TACROLIMUS |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TANNIC ACID |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TANNIC ACID |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
TANNIC ACID |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
TANNIC ACID |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
AMLODIPINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
AMLODIPINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
TANNIC ACID |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
U-78517F |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
U-78517F |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
U-78517F |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
U-78517F |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
CHLORAMPHENICOL |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
TANNIC ACID |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
NALOXONAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
NALOXONAZINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
DOXORUBICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
DOXORUBICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
DOXORUBICIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 4 |
BW-723C86 |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
BW-723C86 |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
BW-723C86 |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DEXAMETHASONE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
CEPHALEXIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
BENZO[E]PYRENE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
BENZO[E]PYRENE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
BENZO[E]PYRENE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
BENZO[E]PYRENE |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
CLOFIBRIC ACID |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
CLOFIBRIC ACID |
CYP450-2C9 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
DOXORUBICIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
6(5H)-PHENANTHRIDINONE |
Adenosine A3 |
-20% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
DOXORUBICIN |
Calcitonin |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ETOPOSIDE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ETOPOSIDE |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
3-METHYLCHOLANTHRENE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
3-METHYLCHOLANTHRENE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
3-METHYLCHOLANTHRENE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
3-METHYLCHOLANTHRENE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
3-METHYLCHOLANTHRENE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
3-METHYLCHOLANTHRENE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
HYDROXYUREA |
Platelet Activating Factor (PAF) |
-20% |
NoneNone |
NoneNone |
View
|
| nitric oxide synthase 3 (endothelial cell) |
3-METHYLCHOLANTHRENE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-20% |
NoneNone |
NoneNone |
View
|
| nitric oxide synthase 3, endothelial cell |
3-METHYLCHOLANTHRENE |
Nitric Oxide Synthase, Constitutive (cNOS) |
-20% |
NoneNone |
NoneNone |
View
|
| cathepsin G |
RIFAMPIN |
Protease, Cathepsin G |
-20% |
NoneNone |
NoneNone |
View
|
| mast cell protease 9 |
RIFAMPIN |
Protease, Cathepsin G |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA3 (alpha 3) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor subunit 4c |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Muscarinic M5 |
-20% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
LACTIC ACID |
Testosterone |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Muscarinic M1 |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
AJMALINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
AJMALINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
MEDROXYPROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
MEDROXYPROGESTERONE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
DIETHYLSTILBESTROL |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
DIETHYLSTILBESTROL |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
GEMFIBROZIL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GEMFIBROZIL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
MIFEPRISTONE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
LY-294002 |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
LY-294002 |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
LY-294002 |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
AMINOSALICYLIC ACID |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
GEMFIBROZIL |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
GEMFIBROZIL |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
THIABENDAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
THIABENDAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
MIFEPRISTONE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
AMRINONE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
DIPYRIDAMOLE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
DIPYRIDAMOLE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
FLUORESCEIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
FLUORESCEIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
FLUPHENAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
FLUPHENAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
FLUPHENAZINE |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
FLUPHENAZINE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
DIFLUNISAL |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase (YT blood group) |
ATORVASTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
ATORVASTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| acetylcholinesterase |
ATORVASTATIN |
Acetylcholinesterase |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
ATORVASTATIN |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
ATORVASTATIN |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
ATORVASTATIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
ATORVASTATIN |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
ATORVASTATIN |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
CLEMASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
CLEMASTINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
KETOTIFEN |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
LEVOCARNITINE |
CYP450-1A2 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, epsilon polypeptide |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 4 |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 5 |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
CLOMIPRAMINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A2a receptor |
CLOZAPINE |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
CARMUSTINE |
Protein Tyrosine Kinase, Lck |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
LOXOPROFEN |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
LOXOPROFEN |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
CARMUSTINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
CARMUSTINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
CARMUSTINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
CARMUSTINE |
Leukotriene B4 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
CARVEDILOL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CARVEDILOL |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|